Korea’s Hub for Pharma, Biopharma, and Health Innovation ‘CPHI/ Hi Korea 2026’, to be held at COEX in August

·       Due to high demand, the exhibition size has expanded with the additional opening of COEX Hall E.

·       Bio Zone has strategically expanded with confirmed key sponsors such as DIPS, Bioneer, and the Jeonnam Bio Foundation.

Seoul, Republic of Korea — Hosted by global exhibition organizer Informa Markets Korea, CPHI/ Hi Korea 2026 will be held at COEX in Seoul from August 25 to 27. The event is supported by major organizations, including Ministry of Food and Drug Safety, Korea Fund for Regenerative Medicine, Korea Institute of Toxicology, Korea Health Functional Food Association, Korea Drug Research Association, Korea Invention Promotion Association, and DIPS. Notably, CPHI Korea Bio Zone is co-hosted with the Korea Biomedicine Industry Association.

This exhibition covers the whole industry, including △Pharma Ingredients and Finished Dosage Forms △Biotech and Bio Pharma △Contract Manufacturing and Services (CDMO, CMO) △Nutraceutical Ingredients and Products △Lab Equipment, Machinery and Packaging. It focuses on providing practical business matching and partnering opportunities for domestic and international exhibitors and buyers.

■ Securing additional Hall due to high demand… Expanding exchanges in the pharma and nutraceutical industries

Both CPHI Korea and Hi Korea have received exceptional industry interest, resulting in early booth closures. To accommodate ongoing inquiries and waitlist applications, the organizers recently expanded the exhibition into COEX Hall E. This larger space will allow more domestic and foreign innovative companies to showcase their latest products.

Alongside top global companies, a newly added Hong Kong Pavilion will join the existing Mainland China Pavilion (run by CCCMHPIE and CCPIT) inside CPHI Korea. This addition provides varied networking opportunities for those entering the Asian market and further elevates the exhibition's international standing.

■ Strategic expansion of the Bio Zone and stronger startup partnering

A key highlight this year is the strategic growth of the CPHI Korea Bio Zone. Bioneer, Korea's first bio-venture company, joins as a gold sponsor with a shared booth for its subsidiary, siRNAgen Therapeutics. The Super Gap startup project DIPS also joins as a gold sponsor, alongside the Jeonnam Bio Foundation as a silver sponsor, adding significant depth to the event.

The Bio Zone will strengthen its startup discovery and partnering functions. Supported companies from partner groups like Korea Biomedicine Industry Association, Jeonnam Bio Foundation, Korea Fund for Regenerative Medicine, and DIPS will use the CPHI platform to seek technology transfers and new markets.

An Informa Markets Korea official stated, “For promising startups lacking a global network, CPHI Korea is the best stage to directly meet buyers and investors, creating real scale-up results.” To encourage participation, the organizer is offering discounted booth fees for innovative tech companies established within the last seven years.

■ Reflecting fast-changing trends… Strengthening Bio Zone content

The Bio Zone will feature main topics like ▲practical strategies for regenerative medicine investment ▲clinical and animal test alternatives ▲obesity treatments (GLP-1) focused on drug delivery systems (DDS) ▲healthcare strategic technologies. Beyond a simple exhibition, it plans to lead the growth of the bio ecosystem by planning ESG management, K-platform tech introductions, open innovation matching between big companies and startups, CVC, and investment meetings.

Additionally, various programs for the pharma and nutraceutical industries will run concurrently. These include global regulatory seminars led by foreign agencies (covering Japan, Southeast Asia, Europe, etc.), major policy briefings, and patent tech meetings.